Magnetic Resonance Spectroscopy [MRS]
Magnetic Resonance Spectroscopy [MRS] is an intervention with 6 clinical trials. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
50.0%
2 of 4 finished
50.0%
2 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
Clinical Trials (6)
Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation
All 6 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 6